Unlock stock picks and a broker-level newsfeed that powers Wall Street.

IOB - Delayed Quote HUF

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. (0QFP.IL)

Compare
5,040.00
0.00
(0.00%)
At close: April 1 at 4:05:30 PM GMT+1

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in HUF.
NameTitlePayExercisedYear Born
Mr. Gabor Orban CEO, Member of Exec. Board & Director -- -- 1979
Mr. Istvan Hamecz CFO, Member of Exec. Board & Director -- -- 1967
Dr. Istvan Greiner R&D Director and Member of Exec. Board -- -- 1960
Mr. Tibor Horvath Commercial Director & Member of Exec. Board -- -- 1974
Ms. Katalin Erdei HR Director & Member of Exec. Board -- -- 1974
Attila Szenasi Director of Pharmaceutical Manufacturing & Member of the Exec. Board -- -- 1984
Mr. Tamas Szolyak Director of Global Regulatory Science & Portfolio Management & Member of Exec. Board -- -- 1966
Mr. Robert Rethy Head of the Investor Relations & ESG Department -- -- --

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.

Gyömroi út 19-21.
Budapest, 1103
Hungary
36 1 431 4000 https://www.richter.hu
Sector: 
Healthcare

Description

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. researches, develops, manufactures, markets, and sells pharmaceutical products worldwide. The company operates through two segments, Pharmaceuticals, and Wholesale and Retail. It develops and manufactures products in various therapeutic areas, including women's healthcare, cardiovascular, and central nervous system. The company offers women's healthcare products for contraceptives, endometriosis, fertility, menopause, vaginal infections, and uterine fibroids. It also provides central nervous system products, such as products for the treatment of chronic cerebral circulatory disorders and neuropathic pain; and aesthetics, anti-anxiety medications, sleeping pills, and anti-epileptic medicines, as well as products for the prevention and treatment of various cardiovascular diseases. In addition, the company produces various over-the-counter products for various health problems comprising Panangin for heart support; Escapelle and Postinor, an emergency contraceptive pill; Stopdiar and Nifuroxazide to treat diarrhea; RICHTER CycleBalance for infertility and PCOS; Curiosin for wound care; Groprinosin for antiviral and immunostimulant; Folik, a pregnancy supplement; Moilec for back and joint pain; Fasconal, a pain relief tablet; Lordestin for allergy; Magnezin, a magnesium supplement; Aflamil, an anti-inflammatory and antirheumatic cream; Oralsept, a sore throat and local anesthetic. Further, it provides financial and accounting, social and welfare, portfolio and project management, catering, carriage transportation, engineering, quality control, trading, asset management, and biotechnological services. Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. was founded in 1901 and is headquartered in Budapest, Hungary.

Corporate Governance

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

May 13, 2025 at 10:59 AM UTC

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. Earnings Date

Recent Events

June 7, 2023 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers